What is AdvisorShares Psychedelics ETF share price today?
AdvisorShares Psychedelics ETF (PSIL) is currently trading at $24.81. You can also track daily change, historical performance, trading volume and other key ETF details on this page.How can I buy AdvisorShares Psychedelics ETF shares from India?
Indian investors can buy AdvisorShares Psychedelics ETF (PSIL) by opening a US investing account through a platform that provides access to US stocks and ETFs, completing the required verification, transferring funds under the Liberalised Remittance Scheme (LRS), and placing an order in USD.Can Indians/NRIs invest in AdvisorShares Psychedelics ETF from India?
Yes, Indian residents and NRIs can invest in AdvisorShares Psychedelics ETF (PSIL) through platforms that offer access to US-listed stocks and ETFs, subject to applicable regulations, including RBI’s Liberalised Remittance Scheme (LRS) guidelines.What is the expense ratio of AdvisorShares Psychedelics ETF?
The expense ratio of AdvisorShares Psychedelics ETF (PSIL) is 0.99%. It represents the annual operating cost charged by the ETF provider for managing the fund and tracking its underlying index.What are AdvisorShares Psychedelics ETF’s top holdings?
AdvisorShares Psychedelics ETF (PSIL)’s top holdings currently include ATAI Life Sciences BV, Compass Pathways Plc, and Definium Therapeutics, Inc.. The ETF’s complete holdings list, allocation and sector exposure are available in the Holdings section on this page.Can I buy fractional shares of AdvisorShares Psychedelics ETF?
Many platforms offering US ETF investing allow fractional investing, enabling Indian investors to buy a portion of AdvisorShares Psychedelics ETF (PSIL) instead of a full share. This allows investment based on a fixed dollar amount.What are the tax implications of investing in AdvisorShares Psychedelics ETF for Indian investors?
Gains from AdvisorShares Psychedelics ETF (PSIL) are generally taxed in India based on the applicable holding period and tax rules. Dividends may be subject to US withholding tax and Indian taxation rules. The final tax treatment depends on individual circumstances.Is there a TCS on remitting money to buy AdvisorShares Psychedelics ETF under LRS?
Remittances under the Liberalised Remittance Scheme (LRS) for overseas investments, including US ETFs like AdvisorShares Psychedelics ETF (PSIL), may attract TCS above specified thresholds. Applicable rates and limits are determined by government regulations and may change over time.What is AdvisorShares Psychedelics ETF’s AUM (assets under management)?
AdvisorShares Psychedelics ETF (PSIL)’s current assets under management (AUM) are $56.28M. AUM represents the total market value of assets managed by the ETF and indicates the size of the fund.What is AdvisorShares Psychedelics ETF’s P/E ratio?
AdvisorShares Psychedelics ETF (PSIL)’s price-to-earnings (P/E) ratio is 23.50. It represents the weighted valuation of the companies held within the ETF relative to their earnings.How does AdvisorShares Psychedelics ETF compare with SPDR Kensho New Economies Composite (KOMP), iShares Global Clean Energy ETF (ICLN), and Invesco Solar ETF (TAN)?
You can compare AdvisorShares Psychedelics ETF (PSIL) with SPDR Kensho New Economies Composite (KOMP), iShares Global Clean Energy ETF (ICLN), and Invesco Solar ETF (TAN) based on metrics such as expense ratio, AUM, P/E ratio, holdings, liquidity and historical returns in the Peers & Comparison section.What is AdvisorShares Psychedelics ETF’s NAV (net asset value) today?
AdvisorShares Psychedelics ETF (PSIL)’s NAV represents the per-unit value of the ETF’s underlying holdings after adjusting for expenses and liabilities. It is calculated once daily after markets close and may differ from the ETF’s live market price.
$
₹
$24.810.91% (+0.22)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
1D
1W
1M
1Y
5Y
Max
Key Metrics
Key Metrics
Expense Ratio
Expense Ratio
The operating and administrative costs of running the fund measured as the percentage of fund assets
0.99%
AUM
AUM
Current market value of the ETF scheme managed by the Asset Management Company
$56.28M
Beta
Beta
Sensitivity of the stock's price relative to the country's key indices over the last 5 years
0.56
Volatility (3Y)
Volatility (3Y)
The annualized standard deviation of the ETF's returns calculated over the last 3 years
46.14%
PE
PE
Ratio of price to the prospective earnings of the ETF's underlyings
23.50
PE Category
PE Category
Ratio of price to the prospective earnings of the holdings of ETFs from the same category
19.10
ETF Profile
Peers
Peers
Exp. Ratio
0.2%
0.2%
PE
19.32
19.32
—
—
1Y Return
16.98%
16.98%
—
—
Exp. Ratio
0.41%
0.41%
PE
17.74
17.74
—
—
1Y Return
24.00%
24.00%
—
—
Exp. Ratio
0.67%
0.67%
PE
15.11
15.11
—
—
1Y Return
14.32%
14.32%
—
—
Exp. Ratio
0.83%
0.83%
PE
57.59
57.59
—
—
1Y Return
11.57%
11.57%
—
—
Exp. Ratio
0.85%
0.85%
PE
19.47
19.47
—
—
1Y Return
13.41%
13.41%
—
—
Peers & Comparison
Peers & Comparison
ETFMiscellaneous Sector
| ETF | Total AUMTotal AUM | Exp. RatioExp. Ratio | 1Y Return1Y Return |
|---|---|---|---|
| AdvisorShares Psychedelics ETF | $56.28M | 0.99% | 43.36% |
| SPDR Kensho New Economies Composite | $2.66B | 0.2% | 16.98% |
| iShares Global Clean Energy ETF | $2.14B | 0.41% | 24.00% |
Price Comparison
Price Comparison
1 Month
1 Year
5 Years
Top Holdings
Top Holdings
- NameHoldingsSector
- ATAI Life Sciences BVSector: HealthcareHoldings11.70 %ATAI Life Sciences BVATAI
Holdings
11.70 %
Healthcare - Compass Pathways PlcSector: HealthcareHoldings11.06 %Compass Pathways PlcCMPS
Holdings
11.06 %
Healthcare - Definium Therapeutics, Inc.Sector: HealthcareHoldings10.87 %Definium Therapeutics, Inc.DFTX
Holdings
10.87 %
Healthcare - Cybin Inc.Sector: HealthcareHoldings7.93 %Cybin Inc.
Holdings
7.93 %
Healthcare - NRX Pharmaceuticals IncSector: HealthcareHoldings4.72 %NRX Pharmaceuticals IncNRXP
Holdings
4.72 %
Healthcare - Alto Neuroscience, Inc.Sector: HealthcareHoldings4.61 %Alto Neuroscience, Inc.ANRO
Holdings
4.61 %
Healthcare - Neuronetics IncSector: HealthcareHoldings4.50 %Neuronetics IncSTIM
Holdings
4.50 %
Healthcare - GH Research PLCSector: HealthcareHoldings4.46 %GH Research PLCGHRS
Holdings
4.46 %
Healthcare - Neurocrine Biosciences IncSector: HealthcareHoldings4.35 %Neurocrine Biosciences IncNBIX
Holdings
4.35 %
Healthcare - Relmada Therapeutics IncSector: HealthcareHoldings4.18 %Relmada Therapeutics IncRLMD
Holdings
4.18 %
Healthcare